Gastroenterology
Volume 137, Issue 2 , Pages 466-481 , August 2009

Stem Cells and Liver Regeneration

  • Andrew W. Duncan

      Affiliations

    • Oregon Stem Cell Center, Oregon Health & Science University, Portland, Oregon
    • ,
  • Craig Dorrell

      Affiliations

    • Oregon Stem Cell Center, Oregon Health & Science University, Portland, Oregon
    • ,
  • Markus Grompe

      Affiliations

    • Oregon Stem Cell Center, Oregon Health & Science University, Portland, Oregon
    • Papé Family Research Institute, Department of Pediatrics, Oregon Health & Science University, Portland, Oregon
    • Corresponding Author InformationReprint requests Address requests for reprints to: Markus Grompe, MD, Papé Family Pediatric Research Institute, Oregon Stem Cell Center, Department of Pediatrics, Oregon Health and Science University, 3181 Southwest Sam Jackson Park Road, Mail Code L321, Portland, Oregon 97239–3098. fax: (503) 418-5044

Received 4 February 2009 ,Accepted 11 May 2009.

References 

  1. Desmet VJ. Organizational principles. In:  Arias IM editors. The liver—biology and pathobiology. New York, NY: Raven; 1994;p. 3–14
  2. Mall FP. A study of the structural unit of the liver. Am J Anat. 1906;5:227–308
  3. Wisse E. An electron microscopic study of the fenestrated endothelial lining of rat liver sinusoids. J Ultrastruct Res. 1970;31:125–150
  4. Jungermann K, Kietzmann T. Zonation of parenchymal and nonparenchymal metabolism in liver. Annu Rev Nutr. 1996;16:179–203
  5. Moorman AF, Vermeulen JL, Charles R, et al. Localization of ammonia-metabolizing enzymes in human liver: ontogenesis of heterogeneity. Hepatology. 1989;9:367–372
  6. Haussinger D, Lamers WH, Moorman AF. Hepatocyte heterogeneity in the metabolism of amino acids and ammonia. Enzyme. 1992;46:72–93
  7. Bucher NLR, Malt RA. Regeneration of liver and kidney. Boston, MA: Little, Brown; 1971;
  8. Zajicek G, Oren R, Weinreb M. The streaming liver. Liver. 1985;5:293–300
  9. Fellous TG, Islam S, Tadrous PJ, et al. Locating the stem cell niche and tracing hepatocyte lineages in human liver. Hepatology. 2009;49:1655–1663
  10. Bralet MP, Branchereau S, Brechot C, et al. Cell lineage study in the liver using retroviral mediated gene transfer (Evidence against the streaming of hepatocytes in normal liver). Am J Pathol. 1994;144:896–905
  11. Shiojiri N, Sano M, Inujima S, et al. Quantitative analysis of cell allocation during liver development, using the spf(ash)-heterozygous female mouse. Am J Pathol. 2000;156:65–75
  12. Thurman RG, Kauffman FC. Sublobular compartmentation of pharmacologic events (SCOPE): metabolic fluxes in periportal and pericentral regions of the liver lobule. Hepatology. 1985;5:144–151
  13. Ponder KP. Analysis of liver development, regeneration, and carcinogenesis by genetic marking studies. FASEB J. 1996;10:673–682
  14. Michalopoulos GK, DeFrances MC. Liver regeneration. Science. 1997;276:60–66
  15. Thorgeirsson SS. Hepatic stem cells in liver regeneration. FASEB J. 1996;10:1249–1256
  16. Michalopoulos GK. Liver regeneration. J Cell Physiol. 2007;213:286–300
  17. Bucher NLR, Swaffield MN. The rate of incorporation of labeled thymidine into the deoxyribonucleic acid of regenerating rat liver in relation to the amount of liver excised. Cancer Res. 1964;240:1611–1625
  18. Stocker E, Pfeifer U. On the manner of proliferation of the liver parenchyma after partial hepatectomy (Autoradiography studies using 3H-thymidine). Naturwissenschaften. 1965;52:663
  19. Lindroos PM, Zarnegar R, Michalopoulos GK. Hepatocyte growth factor (hepatopoietin A) rapidly increases in plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administration. Hepatology. 1991;13:743–750
  20. Short J, Klein K, Kibert L, et al. Involvement of the lodothyronines in liver and hepatoma cell proliferation in the rat. Cancer Res. 1980;40:2417–2422
  21. Cruise JL. Alpha 1-adrenergic receptors in liver regeneration. Dig Dis Sci. 1991;36:485–488
  22. Jirtle RL, Carr BI, Scott CD. Modulation of insulin-like growth factor-II/mannose 6-phosphate receptors and transforming growth factor-beta 1 during liver regeneration. J Biol Chem. 1991;266:22444–22450
  23. Huang W, Ma K, Zhang J, et al. Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration. Science. 2006;312:233–236
  24. Dong J, Feldmann G, Huang J, et al. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell. 2007;130:1120–1133
  25. Shinozuka H, Lombardi B, Sell S, et al. Early histological and functional alterations of ethionine liver carcinogenesis in rats fed a choline-deficient diet. Cancer Res. 1978;38:1092–1098
  26. Dorrell C, Erker L, Lanxon-Cookson KM, et al. Surface markers for the murine oval cell response. Hepatology. 2008;48:1282–1291
  27. Wang X, Foster M, Al-Dhalimy M, et al. The origin and liver repopulating capacity of murine oval cells. Proc Natl Acad Sci U S A. 2003;100(Suppl 1):11881–11888
  28. Alison MR, Golding M, Sarraf CE, et al. Liver damage in the rat induces hepatocyte stem cells from biliary epithelial cells. Gastroenterology. 1996;110:1182–1190
  29. Theise ND, Saxena R, Portmann BC, et al. The canals of Hering and hepatic stem cells in humans. Hepatology. 1999;30:1425–1433
  30. Jung Y, Brown KD, Witek RP, et al. Accumulation of hedgehog-responsive progenitors parallels alcoholic liver disease severity in mice and humans. Gastroenterology. 2008;134:1532–1543
  31. Yang S, Koteish A, Lin H, et al. Oval cells compensate for damage and replicative senescence of mature hepatocytes in mice with fatty liver disease. Hepatology. 2004;39:403–411
  32. Roskams T, Yang SQ, Koteish A, et al. Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease. Am J Pathol. 2003;163:1301–1311
  33. Spagnoli FM, Amicone L, Tripodi M, et al. Identification of a bipotential precursor cell in hepatic cell lines derived from transgenic mice expressing cyto-Met in the liver. J Cell Biol. 1998;143:1101–1112
  34. Strick-Marchand H, Morosan S, Charneau P, et al. Bipotential mouse embryonic liver stem cell lines contribute to liver regeneration and differentiate as bile ducts and hepatocytes. Proc Natl Acad Sci U S A. 2004;101:8360–8365
  35. Sackett SD, Li Z, Hurtt R, et al. Foxl1 is a marker of bipotential hepatic progenitor cells in mice. Hepatology. 2009;49:920–929
  36. Preisegger KH, Factor VM, Fuchsbichler A, et al. Atypical ductular proliferation and its inhibition by transforming growth factor beta1 in the 3,5-diethoxycarbonyl-1,4-dihydrocollidine mouse model for chronic alcoholic liver disease. Lab Invest. 1999;79:103–109
  37. Faktor VM, Engel'gardt NV, Iazova AK, et al. Common antigens of oval cells and cholangiocytes in the mouse (Their detection by using monoclonal antibodies). Ontogenez. 1990;21:625–632
  38. Sanchez A, Factor VM, Schroeder IS, et al. Activation of NF-kappaB and STAT3 in rat oval cells during 2-acetylaminofluorene/partial hepatectomy-induced liver regeneration. Hepatology. 2004;39:376–385
  39. Fujio K, Evarts RP, Hu Z, et al. Expression of stem cell factor and its receptor, c-kit, during liver regeneration from putative stem cells in adult rat. Lab Invest. 1994;70:511–516
  40. Petersen BE, Goff JP, Greenberger JS, et al. Hepatic oval cells express the hematopoietic stem cell marker Thy-1 in the rat. Hepatology. 1998;27:433–445
  41. Spangrude GJ, Heimfeld S, Weissman IL. Purification and characterization of mouse hematopoietic stem cells. Science. 1988;241:58–62
  42. Dezso K, Jelnes P, Laszlo V, et al. Thy-1 is expressed in hepatic myofibroblasts and not oval cells in stem cell-mediated liver regeneration. Am J Pathol. 2007;171:1529–1537
  43. Baumann U, Crosby HA, Ramani P, et al. Expression of the stem cell factor receptor c-kit in normal and diseased pediatric liver: identification of a human hepatic progenitor cell?. Hepatology. 1999;30:112–117
  44. Petersen BE, Grossbard B, Hatch H, et al. Mouse A6-positive hepatic oval cells also express several hematopoietic stem cell markers. Hepatology. 2003;37:632–640
  45. Erker L, Grompe M. Signaling networks in hepatic oval cell activation. Stem Cell Res. 2008;1:90–102
  46. Sun R, Gao B. Negative regulation of liver regeneration by innate immunity (natural killer cells/interferon-gamma). Gastroenterology. 2004;127:1525–1539
  47. Akhurst B, Matthews V, Husk K, et al. Differential lymphotoxin-beta and interferon gamma signaling during mouse liver regeneration induced by chronic and acute injury. Hepatology. 2005;41:327–335
  48. Brooling JT, Campbell JS, Mitchell C, et al. Differential regulation of rodent hepatocyte and oval cell proliferation by interferon gamma. Hepatology. 2005;41:906–915
  49. Matthews VB, Klinken E, Yeoh GC. Direct effects of interleukin-6 on liver progenitor oval cells in culture. Wound Repair Regen. 2004;12:650–656
  50. Knight B, Yeoh GC, Husk KL, et al. Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice. J Exp Med. 2000;192:1809–1818
  51. Jakubowski A, Ambrose C, Parr M, et al. TWEAK induces liver progenitor cell proliferation. J Clin Invest. 2005;115:2330–2340
  52. Fleig SV, Choi SS, Yang L, et al. Hepatic accumulation of Hedgehog-reactive progenitors increases with severity of fatty liver damage in mice. Lab Invest. 2007;87:1227–1239
  53. Sell S, Dunsford HA. Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma. Am J Pathol. 1989;134:1347–1363
  54. Sell S, Leffert HL. An evaluation of cellular lineages in the pathogenesis of experimental hepatocellular carcinoma. Hepatology. 1982;2:77–86
  55. Braun L, Mikumo R, Fausto N. Production of hepatocellular carcinoma by oval cells: cell cycle expression of c-myc and p53 at different stages of oval cell transformation. Cancer Res. 1989;49:1554–1561
  56. Yaswen P, Goyette M, Shank PR, et al. Expression of c-Ki-ras, c-Ha-ras, and c-myc in specific cell types during hepatocarcinogenesis. Mol Cell Biol. 1985;5:780–786
  57. Libbrecht L, Roskams T. Hepatic progenitor cells in human liver diseases. Semin Cell Dev Biol. 2002;13:389–396
  58. Wu PC, Fang JW, Lau VK, et al. Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers (Clinical and biological implications). Am J Pathol. 1996;149:1167–1175
  59. Komuta M, Spee B, Vander Borght S, et al. Clinicopathological study on cholangiocellular carcinoma suggesting hepatic progenitor cell origin. Hepatology. 2008;47:1544–1556
  60. Kobayashi N, Fujiwara T, Westerman KA, et al. Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes. Science. 2000;287:1258–1262
  61. Kobayashi N, Ito M, Nakamura J, et al. Hepatocyte transplantation in rats with decompensated cirrhosis. Hepatology. 2000;31:851–857
  62. Kobayashi N, Miyazaki M, Fukaya K, et al. Establishment of a highly differentiated immortalized human hepatocyte cell line as a source of hepatic function in the bioartificial liver. Transplant Proc. 2000;32:237–241
  63. Gupta S, Chowdhury JR. Hepatocyte transplantation. In:  Arias IM editors. The liver—biology and pathobiology. 3rd ed.. New York, NY: Raven; 1994;p. 1519–1536
  64. Fox IJ, Chowdhury NR, Gupta S, et al. Conditional immortalization of Gunn rat hepatocytes: an ex vivo model for evaluating methods for bilirubin-UDP-glucuronosyltransferase gene transfer. Hepatology. 1995;21:837–846
  65. Suzuki A, Zheng YW, et al. Clonal identification and characterization of self-renewing pluripotent stem cells in the developing liver. J Cell Biol. 2002;156:173–184
  66. Suzuki A, Sekiya S, Onishi M, et al. Flow cytometric isolation and clonal identification of self-renewing bipotent hepatic progenitor cells in adult mouse liver. Hepatology. 2008;48:1964–1978
  67. Schmelzer E, Zhang L, Bruce A, et al. Human hepatic stem cells from fetal and postnatal donors. J Exp Med. 2007;204:1973–1987
  68. Suzuki A, Oyama K, Fukao K. Prospective isolation and enrichment of pancreatic stem/progenitor cells (Conference on Pancreatic Development, Proliferation and Stem Cells). Bethesda, MD: National Institutes of Health; 2001;
  69. Zhang L, Theise N, Chua M, et al. The stem cell niche of human livers: symmetry between development and regeneration. Hepatology. 2008;48:1598–1607
  70. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002;418:41–49
  71. Reyes M, Verfaillie CM. Characterization of multipotent adult progenitor cells, a subpopulation of mesenchymal stem cells. Ann N Y Acad Sci. 2001;938:231–233discussion 233–235
  72. Schwartz RE, Reyes M, Koodie L, et al. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest. 2002;109:1291–1302
  73. Grompe M. Adult versus embryonic stem cells: it's still a tie. Mol Ther. 2002;6:303–305
  74. Aurich H, Sgodda M, Kaltwasser P, et al. Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo. Gut. 2009;58:570–581
  75. Aurich I, Mueller LP, Aurich H, et al. Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers. Gut. 2007;56:405–415
  76. Banas A, Teratani T, Yamamoto Y, et al. Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes. Hepatology. 2007;46:219–228
  77. Miki T, Lehmann T, Cai H, et al. Stem cell characteristics of amniotic epithelial cells. Stem Cells. 2005;23:1549–1559
  78. De Coppi P, Bartsch G, Siddiqui MM, et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol. 2007;25:100–106
  79. Miki T, Marongiu F, Ellis EC, et al. Production of hepatocyte-like cells from human amnion. Methods Mol Biol. 2009;481:1–14
  80. Asahina K, Teramoto K, Teraoka H. Embryonic stem cells: hepatic differentiation and regenerative medicine for the treatment of liver disease. Curr Stem Cell Res Ther. 2006;1:139–156
  81. Gouon-Evans V, Boussemart L, Gadue P, et al. BMP-4 is required for hepatic specification of mouse embryonic stem cell-derived definitive endoderm. Nat Biotechnol. 2006;24:1402–1411
  82. Heo J, Factor VM, Uren T, et al. Hepatic precursors derived from murine embryonic stem cells contribute to regeneration of injured liver. Hepatology. 2006;44:1478–1486
  83. Hay DC, Fletcher J, Payne C, et al. Highly efficient differentiation of hESCs to functional hepatic endoderm requires ActivinA and Wnt3a signaling. Proc Natl Acad Sci U S A. 2008;105:12301–12306
  84. Basma H, Soto-Gutierrez A, Yannam GR, et al. Differentiation and transplantation of human embryonic stem cell–derived hepatocytes. Gastroenterology. 2009;136:767–769
  85. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–676
  86. Coleman WB, Wennerberg AE, Smith GJ, et al. Regulation of the differentiation of diploid and some aneuploid rat liver epithelial (stemlike) cells by the hepatic microenvironment. Am J Pathol. 1993;142:1373–1382
  87. Coleman WB, McCullough KD, Esch GL, et al. Evaluation of the differentiation potential of WB-F344 rat liver epithelial stem-like cells in vivo (Differentiation to hepatocytes after transplantation into dipeptidylpeptidase-IV-deficient rat liver). Am J Pathol. 1997;151:353–359
  88. Dees C, Travis C. Phenotypic and genotypic analysis of rat liver epithelial cells infected with retroviral shuttle vectors. Cancer Lett. 1996;107:19–28
  89. Grisham JW, Coleman WB. Neoformation of liver epithelial cells: progenitor cells, stem cells, and phenotypic transitions. Gastroenterology. 1996;110:1311–1313
  90. Amicone L, Spagnoli FM, Spath G, et al. Transgenic expression in the liver of truncated Met blocks apoptosis and permits immortalization of hepatocytes. EMBO J. 1997;16:495–503
  91. Rogler LE. Selective bipotential differentiation of mouse embryonic hepatoblasts in vitro. Am J Pathol. 1997;150:591–602
  92. Ott M, Ma Q, Li B, et al. Regulation of hepatitis B virus expression in progenitor and differentiated cell types: evidence for negative transcriptional control in nonpermissive cells. Gene Expr. 1999;8:175–186
  93. Ader T, Norel R, Levoci L, et al. Transcriptional profiling implicates TGFbeta/BMP and Notch signaling pathways in ductular differentiation of fetal murine hepatoblasts. Mech Dev. 2006;123:177–194
  94. Nussler AK, Vergani G, Gollin SM, et al. Isolation and characterization of a human hepatic epithelial-like cell line (AKN-1) from a normal liver. In Vitro Cell Dev Biol Anim. 1999;35:190–197
  95. Talbot NC, Rexroad CE, Pursel VG, et al. Culturing the epiblast cells of the pig blastocyst. In Vitro Cell Dev Biol Anim. 1993;29A:534–554
  96. Grompe M. Pancreatic-hepatic switches in vivo. Mech Dev. 2003;120:99–106
  97. Bisgaard HC, Thorgeirsson SS. Evidence for a common cell of origin for primitive epithelial cells isolated from rat liver and pancreas. J Cell Physiol. 1991;147:333–343
  98. Chen JR, Tsao MS, Duguid WP. Hepatocytic differentiation of cultured rat pancreatic ductal epithelial cells after in vivo implantation. Am J Pathol. 1995;147:707–717
  99. Yamanouchi K, Zhou H, Roy-Chowdhury N, et al. Hepatic irradiation augments engraftment of donor cells following hepatocyte transplantation. Hepatology. 2009;49:258–267
  100. Meuleman P, Libbrecht L, De Vos R, et al. Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera. Hepatology. 2005;41:847–856
  101. Dandri M, Burda MR, Torok E, et al. Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus. Hepatology. 2001;33:981–988
  102. Azuma H, Paulk N, Ranade A, et al. Robust expansion of human hepatocytes in Fah−/−/Rag2−/−/Il2rg−/− mice. Nat Biotechnol. 2007;25:903–910
  103. Igarashi Y, Tateno C, Tanaka Y, et al. Engraftment of human hepatocytes in the livers of rats bearing bone marrow reconstructed with immunodeficient mouse bone marrow cells. Xenotransplantation. 2008;15:235–245
  104. Overturf K, Al-Dhalimy M, Ou CN, et al. Serial transplantation reveals the stem-cell-like regenerative potential of adult mouse hepatocytes. Am J Pathol. 1997;151:1273–1280
  105. Overturf K, Al-Dhalimy M, Finegold M, et al. The repopulation potential of hepatocyte populations differing in size and prior mitotic expansion. Am J Pathol. 1999;155:2135–2143
  106. Wang X, Willenbring H, Akkari Y, et al. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature. 2003;422:897–901
  107. Weglarz TC, Degen JL, Sandgren EP. Hepatocyte transplantation into diseased mouse liver (Kinetics of parenchymal repopulation and identification of the proliferative capacity of tetraploid and octaploid hepatocytes). Am J Pathol. 2000;157:1963–1974
  108. Kvittingen EA, Rootwelt H, Berger R, et al. Self-induced correction of the genetic defect in tyrosinemia type I. J Clin Invest. 1994;94:1657–1661
  109. Limaye PB, Bowen WC, Orr AV, et al. Mechanisms of hepatocyte growth factor-mediated and epidermal growth factor-mediated signaling in transdifferentiation of rat hepatocytes to biliary epithelium. Hepatology. 2008;47:1702–1713
  110. Dabeva MD, Petkov PM, Sandhu J, et al. Proliferation and differentiation of fetal liver epithelial progenitor cells after transplantation into adult rat liver. Am J Pathol. 2000;156:2017–2031
  111. Mahieu-Caputo D, Allain JE, Branger J, et al. Repopulation of athymic mouse liver by cryopreserved early human fetal hepatoblasts. Hum Gene Ther. 2004;15:1219–1228
  112. Nierhoff D, Ogawa A, Oertel M, et al. Purification and characterization of mouse fetal liver epithelial cells with high in vivo repopulation capacity. Hepatology. 2005;42:130–139
  113. Oertel M, Menthena A, Chen YQ, et al. Purification of fetal liver stem/progenitor cells containing all the repopulation potential for normal adult rat liver. Gastroenterology. 2008;134:823–832
  114. Dabeva MD, Hwang SG, Vasa SR, et al. Differentiation of pancreatic epithelial progenitor cells into hepatocytes following transplantation into rat liver. Proc Natl Acad Sci U S A. 1997;94:7356–7361
  115. Spooner BS, Walther BT, Rutter WJ. The development of the dorsal and ventral mammalian pancreas in vivo and in vitro. J Cell Biol. 1970;47:235–246
  116. Rutter WJ. The development of the endocrine and exocrine pancreas. Monogr Pathol. 1980;21:30–38
  117. Gerber MA, Thung SN. Cell lineages in human liver development, regeneration and transplantation. In:  Sirica AE editors. The role of cell types in hepatocarcinogenesis. Boca Raton, FL: CRC Press; 1992;p. 209–226
  118. Shiojiri N, Lemire JM, Fausto N. Cell lineages and oval cell progenitors in rat liver development. Cancer Res. 1991;51:2611–2620
  119. Scarpelli DG, Rao MS. Differentiation of regenerating pancreatic cells into hepatocyte-like cells. Proc Natl Acad Sci U S A. 1981;78:2577–2581
  120. Lalwani ND, Reddy MK, Qureshi SA, et al. Development of hepatocellular carcinomas and increased peroxisomal fatty acid beta-oxidation in rats fed [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (Wy-14,643) in the semipurified diet. Carcinogenesis. 1981;2:645–650
  121. Rao MS, Subbarao V, Reddy JK. Induction of hepatocytes in the pancreas of copper-depleted rats following copper repletion. Cell Differ. 1986;18:109–117
  122. Krakowski ML, Kritzik MR, Jones EM, et al. Pancreatic expression of keratinocyte growth factor leads to differentiation of islet hepatocytes and proliferation of duct cells. Am J Pathol. 1999;154:683–691
  123. Hruban RH, Molina JM, Reddy MN, et al. A neoplasm with pancreatic and hepatocellular differentiation presenting with subcutaneous fat necrosis. Am J Clin Pathol. 1987;88:639–645
  124. Wang X, Al-Dhalimy M, Lagasse E, et al. Liver repopulation and correction of metabolic liver disease by transplanted adult mouse pancreatic cells. Am J Pathol. 2001;158:571–579
  125. Terada T, Nakanuma Y. An immunohistochemical survey of amylase isoenzymes in cholangiocarcinoma and hepatocellular carcinoma. Arch Pathol Lab Med. 1993;117:160–162
  126. Yin L, Arenas MS, Clark A, et al. The potentiality of liver oval cells to differentiate into insulin-producing cells (Conference on Pancreatic Development, Proliferation and Stem Cells). Bethesda, MD: National Institutes of Health; 2001;
  127. Kojima H, Fujimiya M, Matsumura K, et al. NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice. Nat Med. 2003;9:596–603
  128. Sapir T, Shternhall K, Meivar-Levy I, et al. Cell-replacement therapy for diabetes: Generating functional insulin-producing tissue from adult human liver cells. Proc Natl Acad Sci U S A. 2005;102:7964–7969
  129. Yan Y, Xu W, Qian H, et al. Mesenchymal stem cells from human umbilical cords ameliorate mouse hepatic injury in vivo. Liver Int. 2009;29:356–365
  130. Banas A, Teratani T, Yamamoto Y, et al. IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury. Stem Cells. 2008;26:2705–2712
  131. Kuo TK, Hung SP, Chuang CH, et al. Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology. 2008;134:2111–21212121.e1–3
  132. Abdel Aziz MT, Atta HM, Mahfouz S, et al. Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis. Clin Biochem. 2007;40:893–899
  133. Banas A, Teratani T, Yamamoto Y, et al. Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure. J Gastroenterol Hepatol. 2009;24:70–77
  134. Carvalho AB, Quintanilha LF, Dias JV, et al. Bone marrow multipotent mesenchymal stromal cells do not reduce fibrosis or improve function in a rat model of severe chronic liver injury. Stem Cells. 2008;26:1307–1314
  135. Russo FP, Alison MR, Bigger BW, et al. The bone marrow functionally contributes to liver fibrosis. Gastroenterology. 2006;130:1807–1821
  136. di Bonzo LV, Ferrero I, Cravanzola C, et al. Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential. Gut. 2008;57:223–231
  137. Parekkadan B, van Poll D, Suganuma K, et al. Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PLoS ONE. 2007;2:e941
  138. van Poll D, Parekkadan B, Cho CH, et al. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology. 2008;47:1634–1643
  139. Petersen BE, Bowen WC, Patrene KD, et al. Bone marrow as a potential source of hepatic oval cells. Science. 1999;284:1168–1170
  140. Theise ND, Badve S, Saxena R, et al. Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation. Hepatology. 2000;31:235–240
  141. Alison MR, Poulsom R, Jeffery R, et al. Hepatocytes from non-hepatic adult stem cells. Nature. 2000;406:257
  142. Theise ND, Nimmakayalu M, Gardner R, et al. Liver from bone marrow in humans. Hepatology. 2000;32:11–16
  143. Lagasse E, Connors H, Al-Dhalimy M, et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med. 2000;6:1229–1234
  144. Danet GH, Luongo JL, Butler G, et al. C1qRp defines a new human stem cell population with hematopoietic and hepatic potential. Proc Natl Acad Sci U S A. 2002;99:10441–10445
  145. Wang X, Ge S, McNamara G, et al. Albumin expressing hepatocyte-like cells develop in the livers of immune-deficient mice transmitted with highly purified human hematopoietic stem cells. Blood. 2003;101:4201–4208
  146. Duncan AW, Hickey RD, Paulk NK, et al. Ploidy reductions in murine fusion-derived hepatocytes. PLoS Genet. 2009;5:e1000385
  147. Vassilopoulos G, Wang PR, Russell DW. Transplanted bone marrow regenerates liver by cell fusion. Nature. 2003;422:901–904
  148. Willenbring H, Bailey AS, Foster M, et al. Myelomonocytic cells are sufficient for therapeutic cell fusion in liver. Nat Med. 2004;10:744–748
  149. Wagers AJ, Sherwood RI, Christensen JL, et al. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science. 2002;297:2256–2259
  150. Wang X, Montini E, Al-Dhalimy M, et al. Kinetics of liver repopulation after bone marrow transplantation. Am J Pathol. 2002;161:565–574
  151. Factor VM, Radaeva SA, Thorgeirsson SS. Origin and fate of oval cells in dipin-induced hepatocarcinogenesis in the mouse. Am J Pathol. 1994;145:409–422
  152. Rosenberg D, Ilic Z, Yin L, et al. Proliferation of hepatic lineage cells of normal C57BL and interleukin-6 knockout mice after cocaine-induced periportal injury. Hepatology. 2000;31:948–955
  153. Teebor GW, Becker FF. Regression and persistence of hyperplastic hepatic nodules induced by N-2-fluorenylacetamide and their relationship to hepatocarcinogenesis. Cancer Res. 1971;31:1–3
  154. Schwarze PE, Pettersen EO, Shoaib MC, et al. Emergence of a population of small, diploid hepatocytes during hepatocarcinogenesis. Carcinogenesis. 1984;5:1267–1275
  155. Solt DB, Medline A, Farber E. Rapid emergence of carcinogen-induced hyperplastic lesions in a new model for the sequential analysis of liver carcinogenesis. Am J Pathol. 1977;88:595–618
  156. Evarts RP, Nakatsukasa H, Marsden ER, et al. Cellular and molecular changes in the early stages of chemical hepatocarcinogenesis in the rat. Cancer Res. 1990;50:3439–3444
  157. Lemire JM, Shiojiri N, Fausto N. Oval cell proliferation and the origin of small hepatocytes in liver injury induced by D-galactosamine. Am J Pathol. 1991;139:535–552
  158. Laconi E, Sarma DS, Pani P. Transplantation of normal hepatocytes modulates the development of chronic liver lesions induced by a pyrrolizidine alkaloid, lasiocarpine. Carcinogenesis. 1995;16:139–142
  159. Laconi E, Oren R, Mukhopadhyay DK, et al. Long-term, near-total liver replacement by transplantation of isolated hepatocytes in rats treated with retrorsine. Am J Pathol. 1998;153:319–329
  160. Gordon GJ, Coleman WB, Hixson DC, et al. Liver regeneration in rats with retrorsine-induced hepatocellular injury proceeds through a novel cellular response. Am J Pathol. 2000;156:607–619
  161. Rhim JA, Sandgren EP, Degen JL, et al. Replacement of diseased mouse liver by hepatic cell transplantation. Science. 1994;263:1149–1152
  162. Overturf K, Al-Dhalimy M, Tanguay R, et al. Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I. Nat Genet. 1996;12:266–273
  163. Braun KM, Degen JL, Sandgren EP. Hepatocyte transplantation in a model of toxin-induced liver disease: variable therapeutic effect during replacement of damaged parenchyma by donor cells. Nat Med. 2000;6:320–326
  164. De Vree JM, Ottenhoff R, Bosma PJ, et al. Correction of liver disease by hepatocyte transplantation in a mouse model of progressive familial intrahepatic cholestasis. Gastroenterology. 2000;119:1720–1730
  165. Mignon A, Guidotti JE, Mitchell C, et al. Selective repopulation of normal mouse liver by Fas/CD95-resistant hepatocytes. Nat Med. 1998;4:1185–1188
  166. Guo D, Fu T, Nelson JA, et al. Liver repopulation after cell transplantation in mice treated with retrorsine and carbon tetrachloride. Transplantation. 2002;73:1818–1824
  167. Guha C, Sharma A, Gupta S, et al. Amelioration of radiation-induced liver damage in partially hepatectomized rats by hepatocyte transplantation. Cancer Res. 1999;59:5871–5874
  168. Dorrell C, Grompe M. Adult liver stem cells. New York, NY: Elsevier; 2006;

 Conflicts of interest The authors disclose the following: Dr Grompe holds equity in Yecuris Inc. This company specializes in humanization of mouse livers. The remaining authors disclose no conflicts.

 Funding Supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases to M.G. (R01DK51592) and A.W.D. (F32DK076232).

PII: S0016-5085(09)00818-X

doi: 10.1053/j.gastro.2009.05.044

Gastroenterology
Volume 137, Issue 2 , Pages 466-481 , August 2009

Article Tools

* Image Usage & Resolution